Acupuncture may help breast cancer patients
Admin • 26 November 2020
Reduce nausea and vomiting after chemotherapy and can also relieve pain

(CNN) – Acupuncture has been practiced in China and other Asian countries for thousands of years. Research has shown the practice can reduce nausea and vomiting after chemotherapy and it can also relieve pain. Now doctors are looking to see if it can help certain breast cancer patients.
When Titi Ariyo was diagnosed with early stage breast cancer, her doctors put her on a treatment that caused her to have some serious side effects.
Titi said, “I had joint pain, my knees and my ankles and my entire body just hurt.”
So her physicians recommended she take part in a trial study that looked at acupuncture as a way to relieve some of her pain. She says it worked.
“I was sleeping better and also the pain reduced.”
Experts say more than 60 percent of women with early stage breast cancer suffer from hot flashes, joint and muscle pain and depression caused by their treatment. They thought if acupuncture could help these patients with some of their discomfort, it could eventually be used as therapy along with the medication.
What they found was both patients who were treated with acupuncture and sham acupuncture, which involves retractable needles, that are not placed in acupuncture pressure points, said they felt some relief.
Dr. Ting Bao said, “Our trial definitely shows there are minimum side effects, and this can potentially help them have significant symptom improvement, both in musculoskeletal symptoms and also hot flashes.”
Dr. Bao theorizes that the pricks from both real and sham acupuncture needles may stimulate the body which can relieve pain and sham or not, acupuncture may be a reasonable alternative to help these women.

Effects of moxibustion for COVID-19 convalescence A protocol for systematic review and meta-analysis
Background: Coronavirus disease 2019 (COVID-19) is still spreading around the world. Moxibustion, as a significant therapy in traditional Chinese medicine (TCM), has been widely used to treat COVID-19, especially in recovery period. The study will aim to assess the efficacy and safety of moxibustion for COVID-19 convalescence. Methods: We will systematically search the relevant randomized controlled trials in the 7 databases from inception to February 2021, including PubMed, MEDLINE, Embase, Cochrane Clinical Trials Database, Web of Science, China National Knowledge Infrastructure and Chinese Biomedical Literature Database. No language and publication status restrictions will be applied. Two reviewers will independently conduct and screen all included studies and the meta-analysis will be performed with RevMan V5.3 (The Cochrane Collaboration, Oxford, England). Results: The study will provide a high-quality convincing assessment of the efficacy and safety of moxibustion for the treatment of COVID-19 convalescence, which will be published in a peer-reviewed journal. Conclusion: Our study will give more comprehensive evidence of the effectiveness of moxibustion for COVID-19 convalescence. Source: https://journals.lww.com/md-journal/Fulltext/2021/04090/Effects_of_moxibustion_for_COVID_19_convalescence_.72.aspx